Reliability and Validity of the Health-Promoting Lifestyle Profile II Spanish Version in University Students

Aim: The purpose of this study was to assess the reliability and validity of the Spanish version of the Health Promoting Lifestyle Profile II (HPLP-II) scale in Colombian university students. Methods: This was a methodological study to verify reliability and construct validity. A total of 763 undergraduate university students in Cali, Colombia, agreed to participate in the study by filling out a form that included information on sociodemographic characteristics and the HPLP-II scale Spanish version. Data were collected between February and June 2021. To determine construct validity, a confirmatory factor analysis was performed, and internal consistency was determined through Cronbach's alpha. Results: The confirmatory factor analysis of the proposed theoretical model showed that the goodness-of-fit indices of the scale demonstrated an acceptable level of validity nearing an excellent level of fit (chi(2) = 7168.98; gl = 1268; p < 0.001; root mean square error of approximation = 0.08; normed fit index, adjusted goodness-of-fit index = 0.95). Cronbach's alpha coefficient of the scale was 0.94, and the subscales ranged from 0.68 to 0.89. Conclusions: The HPLP-II Spanish version is a valid and reliable instrument to assess the health-promoting lifestyle profile of university students

Feminicide in Cali Colombia: A view from public health

Introducción: En la mayoría de ocasiones, la violencia contra la mujer, es cometida por su pareja o expareja, siendo un problema de salud pública mundial que casi siempre termina en un feminicidio. Este se entiende como el asesinato de una mujer por el hecho de serlo, perpetuando la inequidad de género. Objetivo: Visibilizar el feminicidio en Cali a partir de su caracterización epidemiológica. Materiales y métodos: Se realizó un estudio descriptivo de base poblacional de fuentes secundarias, a partir de 287 registros de muertes violentas en mujeres, de los cuales se identificaron y analizaron 53 casos atendidos en la unidad de vida de delitos contra la mujer de la Fiscalía entre el 2017 al 2019, tipificados como feminicidio. La caracterización epidemiológica se realizó con base en la información suministrada que permitió identificar las variables de estudio: edad, mecanismo, lugar de ocurrencia, medida de aseguramiento del victimario y sentencia. Resultados: El feminicidio se presentó entre los 9 y 89 años, el mecanismo más utilizado fue el arma corto punzante. Sólo en el 18,9% se ha dictado sentencia condenatoria. Conclusiones: El feminicidio se presenta en cualquier edad, tiene un alto grado de impunidad en muchas ocasiones por la ineficiencia del sistema judicial

Educational strategies to promote adherence to treatment in patients with cardiovascular disease

INTRODUCTION: Educational material is a key strategy for primary health care promotion. PURPOSE: To design and validate educational material adapted to the population and aimed to increase knowledge about adherence to the treatment of arterial hypertension and diabetes mellitus. METHODOLOGY: Methodological study for the design of educational material for people with diabetes mellitus and high blood pressure. For the design, content validity tests were carried out, with the participation of six experts in health education and six patients with chronic diseases. Validation was performed pursuant to the attraction, understanding, engagement, and acceptance criteria. RESULTS: The validation confirmed that all items and criteria were above the minimal expected range. CONCLUSION: The design and validation of educational material provide elements that improve the education of patients about their pathologies and their adherence to treatment.info:eu-repo/semantics/publishedVersio

Características epidemiológicas en pacientes con eventos tromboembólicos postpandemia en una institución de salud en Colombia

Introducción: Los eventos tromboembólicos desarrollan enfermedades cardiovasculares siendo estas la principal causa de muerte y discapacidad a nivel mundial. Objetivo: Caracterizar el perfil epidemiológico de personas con eventos tromboembólicos post pandemia en una institución de salud de nivel III en Colombia. Método: estudio descriptivo, retrospectivo de corte transversal, con la revisión de 509 historias clínicas de pacientes diagnosticados con eventos tromboembólicos en una Institución de salud de nivel III entre enero de 2021 y diciembre de 2022. Se realizó análisis Univariado para comparar las variables sociodemográficas y clínicas, el análisis Bivariado y regresión logística multivariada determinaron la asociación entre los factores de riesgo y las comorbilidades. Resultados: El 57% de los eventos tromboembólicos se presentaron en el sexo Masculino, siendo más prevalente entre los 62 y 83 años, la comorbilidad más frecuente fue la hipertensión arterial con un 71%. Entre los factores de riesgo para la presencia de eventos tromboembólicos se encontró que el 9 % de la población presentó SRAS-CoV-2. Los eventos tromboembólicos más significativo encontrados en este estudio fueron de tipo arterial como el accidente cerebrovascular. Conclusión: Los eventos tromboembólicos representan una carga significativa en la salud global. La presencia de SRAS-CoV-2 es un factor de riesgo para desarrollar estos eventos.  La identificación temprana de los factores de riesgo, signos y síntomas, permiten el diagnóstico y la intervención oportuna para disminuir las complicaciones y reingresos hospitalarios

Discovering HIV related information by means of association rules and machine learning

Acquired immunodeficiency syndrome (AIDS) is still one of the main health problems worldwide. It is therefore essential to keep making progress in improving the prognosis and quality of life of affected patients. One way to advance along this pathway is to uncover connections between other disorders associated with HIV/AIDS-so that they can be anticipated and possibly mitigated. We propose to achieve this by using Association Rules (ARs). They allow us to represent the dependencies between a number of diseases and other specific diseases. However, classical techniques systematically generate every AR meeting some minimal conditions on data frequency, hence generating a vast amount of uninteresting ARs, which need to be filtered out. The lack of manually annotated ARs has favored unsupervised filtering, even though they produce limited results. In this paper, we propose a semi-supervised system, able to identify relevant ARs among HIV-related diseases with a minimal amount of annotated training data. Our system has been able to extract a good number of relationships between HIV-related diseases that have been previously detected in the literature but are scattered and are often little known. Furthermore, a number of plausible new relationships have shown up which deserve further investigation by qualified medical experts

COVID-19 in hospitalized HIV-positive and HIV-negative patients : A matched study

CatedresObjectives: We compared the characteristics and clinical outcomes of hospitalized individuals with COVID-19 with [people with HIV (PWH)] and without (non-PWH) HIV co-infection in Spain during the first wave of the pandemic. Methods: This was a retrospective matched cohort study. People with HIV were identified by reviewing clinical records and laboratory registries of 10 922 patients in active-follow-up within the Spanish HIV Research Network (CoRIS) up to 30 June 2020. Each hospitalized PWH was matched with five non-PWH of the same age and sex randomly selected from COVID-19@Spain, a multicentre cohort of 4035 patients hospitalized with confirmed COVID-19. The main outcome was all-cause in-hospital mortality. Results: Forty-five PWH with PCR-confirmed COVID-19 were identified in CoRIS, 21 of whom were hospitalized. A total of 105 age/sex-matched controls were selected from the COVID-19@Spain cohort. The median age in both groups was 53 (Q1-Q3, 46-56) years, and 90.5% were men. In PWH, 19.1% were injecting drug users, 95.2% were on antiretroviral therapy, 94.4% had HIV-RNA < 50 copies/mL, and the median (Q1-Q3) CD4 count was 595 (349-798) cells/μL. No statistically significant differences were found between PWH and non-PWH in number of comorbidities, presenting signs and symptoms, laboratory parameters, radiology findings and severity scores on admission. Corticosteroids were administered to 33.3% and 27.4% of PWH and non-PWH, respectively (P = 0.580). Deaths during admission were documented in two (9.5%) PWH and 12 (11.4%) non-PWH (P = 0.800). Conclusions: Our findings suggest that well-controlled HIV infection does not modify the clinical presentation or worsen clinical outcomes of COVID-19 hospitalization

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort : 2004-2013

To analyze the impact of late presentation (LP) on overall mortality and causes of death and describe LP trends and risk factors (2004-2013). Cox models and logistic regression were used to analyze data from a nation-wide cohort in Spain. LP is defined as being diagnosed when CD4 < 350 cells/ml or AIDS. Of 7165 new HIV diagnoses, 46.9% (CI:45.7-48.0) were LP, 240 patients died.First-year mortality was the highest (aHR = 10.3[CI:5.5-19.3]); between 1 and 4 years post-diagnosis, aHR = 1.9(1.2-3.0); an

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

CatedresBackground: To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods: Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results: Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depression. Joint/muscle problems, exhaustion and sleeping disorders were the most commonly reported symptoms among all women. Differences in the prevalences of vaginal dryness (p = 0.002), joint/muscle complaints (p = 0.032), and sweating/flush (p = 0.032) were found among the three groups. Conclusions: Women living with HIV experienced a wide variety of menopausal symptoms, some of them initiated before women had any menstrual irregularity. We found a higher likelihood of somatic symptoms in peri- and post-menopausal women, while a higher likelihood of psychological and urogenital symptoms was found in post-menopausal women. Most somatic symptoms were of low or moderate severity, probably due to the good clinical and immunological situation of these women